Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Quinacrine

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Quinacrine?

Quinacrine is an investigational drug.

There have been 9 clinical trials for Quinacrine. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2005.

The most common disease conditions in clinical trials are Glioblastoma, Carcinoma, Non-Small-Cell Lung, and Creutzfeldt-Jakob Syndrome. The leading clinical trial sponsors are Cleveland BioLabs, University of California, San Francisco, and Milton S. Hershey Medical Center.

Recent Clinical Trials for Quinacrine
The Efficacy of OK-432 Pleurodesis on Postoperative Air LeakNational Taiwan University HospitalN/A
Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinomaMilton S. Hershey Medical CenterPhase 1/Phase 2
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung CancerNeelesh Sharma MD PhDPhase 1

See all Quinacrine clinical trials

Clinical Trial Summary for Quinacrine

Top disease conditions for Quinacrine
Top clinical trial sponsors for Quinacrine

See all Quinacrine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.